Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy
PHASE2CompletedINTERVENTIONAL
Enrollment
51
Participants
Timeline
Start Date
July 31, 2002
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Conditions
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Interventions
DRUG
ixabepilone
Given IV
Trial Locations (1)
19103
Gynecologic Oncology Group, Philadelphia
All Listed Sponsors
collaborator
Gynecologic Oncology Group
NETWORK
lead
National Cancer Institute (NCI)
NIH
NCT00025155 - Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy | Biotech Hunter | Biotech Hunter